$DRTX Insider Trading
FREE EMAIL WATCHDOG
Get free email notifications about insider trading in Durata Therapeutics, Inc..
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insiders | Insider Transactions | Monthly Overview | Weekly Overview
Overview of all insider trading transactions in Durata Therapeutics, Inc.. Get notifications about new insider transactions in Durata Therapeutics, Inc. for free.
Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
---|---|---|---|---|---|---|---|---|---|---|---|
Nov 19 2014 | DRTX | Durata Therapeutic ... | Canaan VIII LP | Director | Option Exercise | D | 16.15 | 8,575 | 138,486 | 0 | |
Nov 19 2014 | DRTX | Durata Therapeutic ... | Canaan VIII LP | Director | Option Exercise | D | 0.00 | 1,216 | 0 | 0 | |
Nov 19 2014 | DRTX | Durata Therapeutic ... | Canaan VIII LP | Director | Sell | D | 0.00 | 5,034 | 0 | 0 | 5 K to 0 (-100.00 %) |
Nov 19 2014 | DRTX | Durata Therapeutic ... | Canaan VIII LP | Director | Sell | U | 0.00 | 1,902,030 | 0 | 0 | 1.9 M to 0 (-100.00 %) |
Nov 19 2014 | DRTX | Durata Therapeutic ... | Ahrens Brenton Karl | Director | Option Exercise | D | 16.15 | 8,575 | 138,486 | 0 | |
Nov 19 2014 | DRTX | Durata Therapeutic ... | Ahrens Brenton Karl | Director | Option Exercise | D | 0.00 | 1,216 | 0 | 0 | |
Nov 19 2014 | DRTX | Durata Therapeutic ... | Ahrens Brenton Karl | Director | Sell | D | 0.00 | 5,034 | 0 | 0 | 5 K to 0 (-100.00 %) |
Nov 19 2014 | DRTX | Durata Therapeutic ... | Ahrens Brenton Karl | Director | Sell | U | 0.00 | 1,902,030 | 0 | 0 | 1.9 M to 0 (-100.00 %) |
Nov 19 2014 | DRTX | Durata Therapeutic ... | Canaan VIII LP | Director | Option Exercise | M | 0.00 | 1,216 | 0 | 1,216 | |
Nov 19 2014 | DRTX | Durata Therapeutic ... | Canaan VIII LP | Director | Option Exercise | M | 2.08 | 6,250 | 13,000 | 0 | |
Nov 19 2014 | DRTX | Durata Therapeutic ... | Canaan VIII LP | Director | Buy | M | 2.08 | 5,034 | 10,471 | 5,034 | 0 to 5 K |
Nov 19 2014 | DRTX | Durata Therapeutic ... | Ahrens Brenton Karl | Director | Option Exercise | M | 0.00 | 1,216 | 0 | 1,216 | |
Nov 19 2014 | DRTX | Durata Therapeutic ... | Ahrens Brenton Karl | Director | Option Exercise | M | 2.08 | 6,250 | 13,000 | 0 | |
Nov 19 2014 | DRTX | Durata Therapeutic ... | Ahrens Brenton Karl | Director | Buy | M | 2.08 | 5,034 | 10,471 | 5,034 | 0 to 5 K |
Nov 19 2014 | DRTX | Durata Therapeutic ... | FRIEDMAN PAUL A | Director | Option Exercise | D | 16.15 | 8,575 | 138,486 | 0 | |
Nov 19 2014 | DRTX | Durata Therapeutic ... | FRIEDMAN PAUL A | Director | Option Exercise | D | 7.16 | 11,145 | 79,798 | 0 | |
Nov 19 2014 | DRTX | Durata Therapeutic ... | Giles Lisa M. | Director | Option Exercise | D | 16.15 | 8,575 | 138,486 | 0 | |
Nov 19 2014 | DRTX | Durata Therapeutic ... | Giles Lisa M. | Director | Option Exercise | D | 7.16 | 11,145 | 79,798 | 0 | |
Nov 19 2014 | DRTX | Durata Therapeutic ... | Giles Lisa M. | Director | Option Exercise | D | 7.16 | 1,875 | 13,425 | 0 | |
Nov 19 2014 | DRTX | Durata Therapeutic ... | Giles Lisa M. | Director | Option Exercise | D | 9.38 | 6,250 | 58,625 | 0 | |
Nov 19 2014 | DRTX | Durata Therapeutic ... | Giles Lisa M. | Director | Sell | D | 0.00 | 2,500 | 0 | 0 | 2.5 K to 0 (-100.00 %) |
Nov 19 2014 | DRTX | Durata Therapeutic ... | DE SCHUTTER RICHARD U | Director | Option Exercise | D | 16.15 | 10,290 | 166,184 | 0 | |
Nov 19 2014 | DRTX | Durata Therapeutic ... | DE SCHUTTER RICHARD U | Director | Option Exercise | D | 7.16 | 14,489 | 103,741 | 0 | |
Nov 19 2014 | DRTX | Durata Therapeutic ... | DE SCHUTTER RICHARD U | Director | Option Exercise | D | 7.16 | 1,876 | 13,432 | 0 | |
Nov 19 2014 | DRTX | Durata Therapeutic ... | DE SCHUTTER RICHARD U | Director | Option Exercise | D | 7.16 | 1,250 | 8,950 | 0 | |
Nov 19 2014 | DRTX | Durata Therapeutic ... | DE SCHUTTER RICHARD U | Director | Option Exercise | D | 10.00 | 4,375 | 43,750 | 0 | |
Nov 19 2014 | DRTX | Durata Therapeutic ... | DE SCHUTTER RICHARD U | Director | Sell | D | 0.00 | 12,500 | 0 | 0 | 12.5 K to 0 (-100.00 %) |
Nov 19 2014 | DRTX | Durata Therapeutic ... | DE SCHUTTER RICHARD U | Director | Sell | D | 0.00 | 15,000 | 0 | 0 | 15 K to 0 (-100.00 %) |
Nov 18 2014 | DRTX | Durata Therapeutic ... | OBOYLE KEVIN C | Director | Option Exercise | D | 16.15 | 8,575 | 138,486 | 0 | |
Nov 18 2014 | DRTX | Durata Therapeutic ... | OBOYLE KEVIN C | Director | Option Exercise | D | 7.16 | 11,145 | 79,798 | 0 | |
Nov 18 2014 | DRTX | Durata Therapeutic ... | OBOYLE KEVIN C | Director | Option Exercise | D | 7.16 | 2,813 | 20,141 | 0 | |
Nov 18 2014 | DRTX | Durata Therapeutic ... | OBOYLE KEVIN C | Director | Option Exercise | D | 7.16 | 1,875 | 13,425 | 0 | |
Nov 18 2014 | DRTX | Durata Therapeutic ... | OBOYLE KEVIN C | Director | Option Exercise | D | 10.00 | 1,875 | 18,750 | 0 | |
Nov 18 2014 | DRTX | Durata Therapeutic ... | OBOYLE KEVIN C | Director | Option Exercise | D | 10.00 | 6,250 | 62,500 | 0 | |
Nov 18 2014 | DRTX | Durata Therapeutic ... | OBOYLE KEVIN C | Director | Sell | D | 0.00 | 5,000 | 0 | 0 | 5 K to 0 (-100.00 %) |
Nov 18 2014 | DRTX | Durata Therapeutic ... | Fishman Corey N. | CFO&COO | Option Exercise | D | 16.15 | 110,000 | 1,776,500 | 0 | |
Nov 18 2014 | DRTX | Durata Therapeutic ... | Fishman Corey N. | CFO&COO | Option Exercise | D | 7.49 | 50,000 | 374,500 | 0 | |
Nov 18 2014 | DRTX | Durata Therapeutic ... | Fishman Corey N. | CFO&COO | Option Exercise | D | 10.00 | 12,500 | 125,000 | 0 | |
Nov 18 2014 | DRTX | Durata Therapeutic ... | Fishman Corey N. | CFO&COO | Option Exercise | D | 10.00 | 21,574 | 215,740 | 0 | |
Nov 18 2014 | DRTX | Durata Therapeutic ... | Fishman Corey N. | CFO&COO | Option Exercise | D | 0.96 | 218,750 | 210,000 | 0 | |
Nov 18 2014 | DRTX | Durata Therapeutic ... | Fishman Corey N. | CFO&COO | Sell | D | 0.00 | 24,941 | 0 | 0 | 24.9 K to 0 (-100.00 %) |
Nov 18 2014 | DRTX | Durata Therapeutic ... | CARROLL J MARTIN | Director | Option Exercise | D | 16.77 | 8,134 | 136,407 | 0 | |
Nov 18 2014 | DRTX | Durata Therapeutic ... | YARNO WENDY L | Director | Option Exercise | D | 16.77 | 8,134 | 136,407 | 0 | |
Nov 18 2014 | DRTX | Durata Therapeutic ... | Shannon John Patrick Jr | Chief Commercial Of ... | Option Exercise | D | 16.15 | 75,000 | 1,211,250 | 0 | |
Nov 18 2014 | DRTX | Durata Therapeutic ... | Shannon John Patrick Jr | Chief Commercial Of ... | Option Exercise | D | 7.49 | 20,000 | 149,800 | 0 | |
Nov 18 2014 | DRTX | Durata Therapeutic ... | Shannon John Patrick Jr | Chief Commercial Of ... | Option Exercise | D | 2.08 | 93,750 | 195,000 | 0 | |
Nov 18 2014 | DRTX | Durata Therapeutic ... | Shannon John Patrick Jr | Chief Commercial Of ... | Sell | D | 0.00 | 11,000 | 0 | 0 | 11 K to 0 (-100.00 %) |
Nov 18 2014 | DRTX | Durata Therapeutic ... | Edick Paul R | Chief Executive Off ... | Option Exercise | D | 16.15 | 300,000 | 4,845,000 | 0 | |
Nov 18 2014 | DRTX | Durata Therapeutic ... | Edick Paul R | Chief Executive Off ... | Option Exercise | D | 7.49 | 100,000 | 749,000 | 0 | |
Nov 18 2014 | DRTX | Durata Therapeutic ... | Edick Paul R | Chief Executive Off ... | Option Exercise | D | 10.00 | 12,500 | 125,000 | 0 | |
Nov 18 2014 | DRTX | Durata Therapeutic ... | Edick Paul R | Chief Executive Off ... | Option Exercise | D | 10.00 | 42,234 | 422,340 | 0 | |
Nov 18 2014 | DRTX | Durata Therapeutic ... | Edick Paul R | Chief Executive Off ... | Option Exercise | D | 0.96 | 656,250 | 630,000 | 0 | |
Nov 18 2014 | DRTX | Durata Therapeutic ... | Edick Paul R | Chief Executive Off ... | Sell | D | 0.00 | 500 | 0 | 0 | 500 to 0 (-100.00 %) |
Nov 18 2014 | DRTX | Durata Therapeutic ... | Edick Paul R | Chief Executive Off ... | Sell | D | 0.00 | 45,636 | 0 | 0 | 45.6 K to 0 (-100.00 %) |
Nov 18 2014 | DRTX | Durata Therapeutic ... | Dunne Michael W. | Chief Medical Offic ... | Option Exercise | D | 16.15 | 100,000 | 1,615,000 | 0 | |
Nov 18 2014 | DRTX | Durata Therapeutic ... | Dunne Michael W. | Chief Medical Offic ... | Option Exercise | D | 7.49 | 50,000 | 374,500 | 0 | |
Nov 18 2014 | DRTX | Durata Therapeutic ... | Dunne Michael W. | Chief Medical Offic ... | Option Exercise | D | 10.00 | 12,500 | 125,000 | 0 | |
Nov 18 2014 | DRTX | Durata Therapeutic ... | Dunne Michael W. | Chief Medical Offic ... | Option Exercise | D | 10.00 | 18,850 | 188,500 | 0 | |
Nov 18 2014 | DRTX | Durata Therapeutic ... | Dunne Michael W. | Chief Medical Offic ... | Option Exercise | D | 0.96 | 281,250 | 270,000 | 0 | |
Nov 18 2014 | DRTX | Durata Therapeutic ... | Dunne Michael W. | Chief Medical Offic ... | Sell | D | 0.00 | 13,220 | 0 | 0 | 13.2 K to 0 (-100.00 %) |
Nov 18 2014 | DRTX | Durata Therapeutic ... | New Leaf Ventures II, L.P. | 10% Owner | Sell | D | 0.00 | 3,028,439 | 0 | 0 | 3 M to 0 (-100.00 %) |
Nov 18 2014 | DRTX | Durata Therapeutic ... | Domain Partners VIII, L.P. | 10% Owner | Sell | D | 0.00 | 3,006,132 | 0 | 0 | 3 M to 0 (-100.00 %) |
Nov 18 2014 | DRTX | Durata Therapeutic ... | DP VIII Associates, L.P. | 10% Owner | Sell | D | 0.00 | 22,306 | 0 | 0 | 22.3 K to 0 (-100.00 %) |
Nov 18 2014 | DRTX | Durata Therapeutic ... | DOMAIN ASSOCIATES | 10% Owner | Sell | D | 0.00 | 6,250 | 0 | 0 | 6.3 K to 0 (-100.00 %) |
Nov 18 2014 | DRTX | Durata Therapeutic ... | VITULLO NICOLE | Director | Option Exercise | D | 16.15 | 8,575 | 138,486 | 0 | |
Aug 28 2014 | DRTX | Durata Therapeutic ... | CARROLL J MARTIN | Director | Option Exercise | A | 16.77 | 8,134 | 136,407 | 8,134 | |
Aug 28 2014 | DRTX | Durata Therapeutic ... | YARNO WENDY L | Director | Option Exercise | A | 16.77 | 8,134 | 136,407 | 8,134 | |
Aug 13 2014 | DRTX | Durata Therapeutic ... | Shannon John Patrick Jr | Chief Commercial Of ... | Buy | P | 13.72 | 3,000 | 41,160 | 11,000 | 8 K to 11 K (+37.50 %) |
Jun 13 2014 | DRTX | Durata Therapeutic ... | Edick Paul R | Chief Executive Off ... | Buy | P | 15.23 | 3,000 | 45,690 | 45,636 | 42.6 K to 45.6 K (+7.04 %) |
May 23 2014 | DRTX | Durata Therapeutic ... | Canaan VIII LP | Director | Option Exercise | A | 16.15 | 8,575 | 138,486 | 14,825 | |
May 23 2014 | DRTX | Durata Therapeutic ... | Ahrens Brenton Karl | Director | Option Exercise | A | 16.15 | 8,575 | 138,486 | 14,825 | |
May 23 2014 | DRTX | Durata Therapeutic ... | FRIEDMAN PAUL A | Director | Option Exercise | A | 16.15 | 8,575 | 138,486 | 19,720 | |
May 23 2014 | DRTX | Durata Therapeutic ... | OBOYLE KEVIN C | Director | Option Exercise | A | 16.15 | 8,575 | 138,486 | 32,533 | |
May 23 2014 | DRTX | Durata Therapeutic ... | HUNT RONALD | Director | Option Exercise | A | 16.15 | 8,575 | 138,486 | 8,575 | |
May 22 2014 | DRTX | Durata Therapeutic ... | Giles Lisa M. | Director | Option Exercise | A | 16.15 | 8,575 | 138,486 | 27,845 | |
May 22 2014 | DRTX | Durata Therapeutic ... | DE SCHUTTER RICHARD U | Director | Option Exercise | A | 16.15 | 10,290 | 166,184 | 32,280 | |
May 22 2014 | DRTX | Durata Therapeutic ... | Fishman Corey N. | CFO & COO | Option Exercise | A | 16.15 | 110,000 | 1,776,500 | 412,824 | |
May 22 2014 | DRTX | Durata Therapeutic ... | Edick Paul R | Chief Executive Off ... | Option Exercise | A | 16.15 | 300,000 | 4,845,000 | 1,110,984 | |
May 22 2014 | DRTX | Durata Therapeutic ... | Dunne Michael W. | Chief Medical Offic ... | Option Exercise | A | 16.15 | 100,000 | 1,615,000 | 462,600 | |
May 22 2014 | DRTX | Durata Therapeutic ... | Shannon John Patrick Jr | Chief Commercial Of ... | Option Exercise | A | 16.15 | 75,000 | 1,211,250 | 188,750 | |
May 22 2014 | DRTX | Durata Therapeutic ... | AISLING CAPITAL III LP | 10% Owner | Sell | J | 0.00 | 3,528 | 0 | 0 | 3.5 K to 0 (-100.00 %) |
May 22 2014 | DRTX | Durata Therapeutic ... | AISLING CAPITAL III LP | 10% Owner | Sell | J | 0.00 | 745,730 | 0 | 2,280,175 | 3 M to 2.3 M (-24.64 %) |
May 22 2014 | DRTX | Durata Therapeutic ... | VITULLO NICOLE | Director | Option Exercise | A | 16.15 | 8,575 | 138,486 | 8,575 | |
May 14 2014 | DRTX | Durata Therapeutic ... | DE SCHUTTER RICHARD U | Director | Buy | P | 15.57 | 15,000 | 233,505 | 15,000 | 0 to 15 K |
Mar 21 2014 | DRTX | Durata Therapeutic ... | AISLING CAPITAL III LP | 10% Owner | Sell | S | 15.57 | 2,649 | 41,255 | 3,030,175 | 3 M to 3 M (-0.09 %) |
Mar 21 2014 | DRTX | Durata Therapeutic ... | AISLING CAPITAL III LP | 10% Owner | Sell | S | 15.74 | 98,000 | 1,542,589 | 3,032,824 | 3.1 M to 3 M (-3.13 %) |
Jan 23 2014 | DRTX | Durata Therapeutic ... | Giles Lisa M. | Director | Buy | P | 8.25 | 500 | 4,125 | 1,500 | 1,000 to 1.5 K (+50.00 %) |
Dec 03 2013 | DRTX | Durata Therapeutic ... | Giles Lisa M. | Director | Buy | P | 10.95 | 1,000 | 10,950 | 1,000 | 0 to 1,000 |
May 20 2013 | DRTX | Durata Therapeutic ... | FRIEDMAN PAUL A | Director | Option Exercise | A | 7.16 | 11,145 | 79,798 | 11,145 | |
May 20 2013 | DRTX | Durata Therapeutic ... | Giles Lisa M. | Director | Option Exercise | A | 7.16 | 11,145 | 79,798 | 19,270 | |
May 20 2013 | DRTX | Durata Therapeutic ... | Giles Lisa M. | Director | Option Exercise | A | 7.16 | 1,875 | 13,425 | 8,125 | |
May 20 2013 | DRTX | Durata Therapeutic ... | OBOYLE KEVIN C | Director | Option Exercise | A | 7.16 | 11,145 | 79,798 | 23,958 | |
May 20 2013 | DRTX | Durata Therapeutic ... | OBOYLE KEVIN C | Director | Option Exercise | A | 7.16 | 1,875 | 13,425 | 12,813 | |
May 20 2013 | DRTX | Durata Therapeutic ... | OBOYLE KEVIN C | Director | Option Exercise | A | 7.16 | 2,813 | 20,141 | 10,938 | |
May 20 2013 | DRTX | Durata Therapeutic ... | DE SCHUTTER RICHARD U | Director | Option Exercise | A | 7.16 | 14,489 | 103,741 | 21,990 | |
May 20 2013 | DRTX | Durata Therapeutic ... | DE SCHUTTER RICHARD U | Director | Option Exercise | A | 7.16 | 1,250 | 8,950 | 7,501 | |
May 20 2013 | DRTX | Durata Therapeutic ... | DE SCHUTTER RICHARD U | Director | Option Exercise | A | 7.16 | 1,876 | 13,432 | 6,251 | |
May 20 2013 | DRTX | Durata Therapeutic ... | Edick Paul R | Chief Executive Off ... | Buy | P | 7.09 | 3,000 | 21,267 | 43,136 | 40.1 K to 43.1 K (+7.47 %) |
Feb 14 2013 | DRTX | Durata Therapeutic ... | Dunne Michael W. | Chief Medical Offic ... | Option Exercise | A | 7.49 | 50,000 | 374,500 | 362,600 | |
Feb 14 2013 | DRTX | Durata Therapeutic ... | Fishman Corey N. | CFO & COO | Option Exercise | A | 7.49 | 50,000 | 374,500 | 302,824 | |
Feb 14 2013 | DRTX | Durata Therapeutic ... | Edick Paul R | Chief Executive Off ... | Option Exercise | A | 7.49 | 100,000 | 749,000 | 810,984 | |
Feb 14 2013 | DRTX | Durata Therapeutic ... | Shannon John Patrick Jr | Chief Commercial Of ... | Option Exercise | A | 7.49 | 20,000 | 149,800 | 113,750 | |
Aug 16 2012 | DRTX | Durata Therapeutic ... | Edick Paul R | Chief Executive Off ... | Buy | P | 8.65 | 5,000 | 43,250 | 24,636 | 19.6 K to 24.6 K (+25.46 %) |
Jul 26 2012 | DRTX | Durata Therapeutic ... | Canaan VIII LP | Director | Option Exercise | A | 2.08 | 6,250 | 13,000 | 6,250 | |
Jul 26 2012 | DRTX | Durata Therapeutic ... | Canaan VIII LP | Director | Option Exercise | C | 0.00 | 10,771,804 | 0 | 0 | |
Jul 26 2012 | DRTX | Durata Therapeutic ... | Canaan VIII LP | Director | Buy | P | 9.00 | 555,555 | 4,999,995 | 1,902,030 | 1.3 M to 1.9 M (+41.26 %) |
Jul 26 2012 | DRTX | Durata Therapeutic ... | Canaan VIII LP | Director | Buy | C | 0.00 | 1,346,475 | 0 | 1,346,475 | 0 to 1.3 M |
Jul 26 2012 | DRTX | Durata Therapeutic ... | Ahrens Brenton Karl | Director | Option Exercise | A | 2.08 | 6,250 | 13,000 | 6,250 | |
Jul 26 2012 | DRTX | Durata Therapeutic ... | Ahrens Brenton Karl | Director | Option Exercise | C | 0.00 | 10,771,804 | 0 | 0 | |
Jul 26 2012 | DRTX | Durata Therapeutic ... | Ahrens Brenton Karl | Director | Buy | P | 9.00 | 555,555 | 4,999,995 | 1,902,030 | 1.3 M to 1.9 M (+41.26 %) |
Jul 26 2012 | DRTX | Durata Therapeutic ... | Ahrens Brenton Karl | Director | Buy | C | 0.00 | 1,346,475 | 0 | 1,346,475 | 0 to 1.3 M |
Jul 26 2012 | DRTX | Durata Therapeutic ... | HUNT RONALD | Director | Option Exercise | C | 0.00 | 17,953,008 | 0 | 0 | |
Jul 26 2012 | DRTX | Durata Therapeutic ... | HUNT RONALD | Director | Buy | P | 9.00 | 784,313 | 7,058,817 | 3,028,439 | 2.2 M to 3 M (+34.95 %) |
Jul 26 2012 | DRTX | Durata Therapeutic ... | HUNT RONALD | Director | Buy | C | 0.00 | 2,244,126 | 0 | 2,244,126 | 0 to 2.2 M |
Jul 26 2012 | DRTX | Durata Therapeutic ... | HORNER GEORGE F III | Director | Option Exercise | C | 0.00 | 448,825 | 0 | 0 | |
Jul 26 2012 | DRTX | Durata Therapeutic ... | HORNER GEORGE F III | Director | Option Exercise | C | 0.96 | 15,625 | 15,000 | 15,625 | |
Jul 26 2012 | DRTX | Durata Therapeutic ... | HORNER GEORGE F III | Director | Option Exercise | P | 0.00 | 127,907 | 0 | 448,825 | |
Jul 26 2012 | DRTX | Durata Therapeutic ... | HORNER GEORGE F III | Director | Buy | C | 0.00 | 56,103 | 0 | 71,728 | 15.6 K to 71.7 K (+359.06 %) |
Jul 26 2012 | DRTX | Durata Therapeutic ... | HORNER GEORGE F III | Director | Buy | C | 0.96 | 15,625 | 15,000 | 15,625 | 0 to 15.6 K |
Jul 26 2012 | DRTX | Durata Therapeutic ... | Dunne Michael W. | Chief Medical Offic ... | Option Exercise | C | 0.00 | 89,764 | 0 | 0 | |
Jul 26 2012 | DRTX | Durata Therapeutic ... | Dunne Michael W. | Chief Medical Offic ... | Option Exercise | P | 0.00 | 25,581 | 0 | 89,764 | |
Jul 26 2012 | DRTX | Durata Therapeutic ... | Dunne Michael W. | Chief Medical Offic ... | Buy | C | 0.00 | 11,220 | 0 | 11,220 | 0 to 11.2 K |
Jul 26 2012 | DRTX | Durata Therapeutic ... | Edick Paul R | Chief Executive Off ... | Option Exercise | C | 0.00 | 157,088 | 0 | 0 | |
Jul 26 2012 | DRTX | Durata Therapeutic ... | Edick Paul R | Chief Executive Off ... | Option Exercise | P | 0.00 | 44,767 | 0 | 157,088 | |
Jul 26 2012 | DRTX | Durata Therapeutic ... | Edick Paul R | Chief Executive Off ... | Buy | C | 0.00 | 19,636 | 0 | 19,636 | 0 to 19.6 K |
Jul 26 2012 | DRTX | Durata Therapeutic ... | New Leaf Ventures II, L.P. | 10% Owner | Option Exercise | C | 0.00 | 17,953,008 | 0 | 0 | |
Jul 26 2012 | DRTX | Durata Therapeutic ... | New Leaf Ventures II, L.P. | 10% Owner | Buy | P | 9.00 | 784,313 | 7,058,817 | 3,028,439 | 2.2 M to 3 M (+34.95 %) |
Jul 26 2012 | DRTX | Durata Therapeutic ... | New Leaf Ventures II, L.P. | 10% Owner | Buy | C | 0.00 | 2,244,126 | 0 | 2,244,126 | 0 to 2.2 M |
Jul 26 2012 | DRTX | Durata Therapeutic ... | Fishman Corey N. | COO & CFO | Option Exercise | C | 0.00 | 179,531 | 0 | 0 | |
Jul 26 2012 | DRTX | Durata Therapeutic ... | Fishman Corey N. | COO & CFO | Option Exercise | P | 0.00 | 51,163 | 0 | 179,531 | |
Jul 26 2012 | DRTX | Durata Therapeutic ... | Fishman Corey N. | COO & CFO | Buy | C | 0.00 | 22,441 | 0 | 22,441 | 0 to 22.4 K |
Jul 25 2012 | DRTX | Durata Therapeutic ... | HEALY JAMES | Director | Option Exercise | C | 0.00 | 1,683,094 | 0 | 0 | |
Jul 25 2012 | DRTX | Durata Therapeutic ... | HEALY JAMES | Director | Buy | P | 9.00 | 588,236 | 5,294,124 | 2,271,330 | 1.7 M to 2.3 M (+34.95 %) |
Jul 25 2012 | DRTX | Durata Therapeutic ... | HEALY JAMES | Director | Buy | C | 0.00 | 1,683,094 | 0 | 1,683,094 | 0 to 1.7 M |
Jul 25 2012 | DRTX | Durata Therapeutic ... | GOLDSTEIN DOV A MD | Director | Option Exercise | C | 0.00 | 16,157,707 | 0 | 0 | |
Jul 25 2012 | DRTX | Durata Therapeutic ... | GOLDSTEIN DOV A MD | Director | Buy | P | 9.00 | 1,111,111 | 9,999,999 | 3,130,824 | 2 M to 3.1 M (+55.01 %) |
Jul 25 2012 | DRTX | Durata Therapeutic ... | GOLDSTEIN DOV A MD | Director | Buy | C | 0.00 | 2,019,713 | 0 | 2,019,713 | 0 to 2 M |
Jul 25 2012 | DRTX | Durata Therapeutic ... | AISLING CAPITAL III LP | 10% Owner | Option Exercise | C | 0.00 | 16,157,707 | 0 | 0 | |
Jul 25 2012 | DRTX | Durata Therapeutic ... | AISLING CAPITAL III LP | 10% Owner | Buy | P | 9.00 | 1,111,111 | 9,999,999 | 3,130,824 | 2 M to 3.1 M (+55.01 %) |
Jul 25 2012 | DRTX | Durata Therapeutic ... | AISLING CAPITAL III LP | 10% Owner | Buy | C | 0.00 | 2,019,713 | 0 | 2,019,713 | 0 to 2 M |
Jul 24 2012 | DRTX | Durata Therapeutic ... | Halak Brian K | 10% Owner | Option Exercise | C | 0.00 | 16,529 | 0 | 0 | |
Jul 24 2012 | DRTX | Durata Therapeutic ... | Halak Brian K | 10% Owner | Option Exercise | C | 0.00 | 2,227,596 | 0 | 0 | |
Jul 24 2012 | DRTX | Durata Therapeutic ... | Halak Brian K | 10% Owner | Buy | P | 9.00 | 5,777 | 51,993 | 22,306 | 16.5 K to 22.3 K (+34.95 %) |
Jul 24 2012 | DRTX | Durata Therapeutic ... | Halak Brian K | 10% Owner | Buy | C | 0.00 | 16,529 | 0 | 16,529 | 0 to 16.5 K |
Jul 24 2012 | DRTX | Durata Therapeutic ... | Halak Brian K | 10% Owner | Buy | P | 9.00 | 778,536 | 7,006,824 | 3,006,132 | 2.2 M to 3 M (+34.95 %) |
Jul 24 2012 | DRTX | Durata Therapeutic ... | Halak Brian K | 10% Owner | Buy | C | 0.00 | 2,227,596 | 0 | 2,227,596 | 0 to 2.2 M |
Jul 24 2012 | DRTX | Durata Therapeutic ... | BLAIR JAMES C | 10% Owner | Option Exercise | C | 0.00 | 16,529 | 0 | 0 | |
Jul 24 2012 | DRTX | Durata Therapeutic ... | BLAIR JAMES C | 10% Owner | Option Exercise | C | 0.00 | 2,227,596 | 0 | 0 | |
Jul 24 2012 | DRTX | Durata Therapeutic ... | BLAIR JAMES C | 10% Owner | Buy | P | 9.00 | 5,777 | 51,993 | 22,306 | 16.5 K to 22.3 K (+34.95 %) |
Jul 24 2012 | DRTX | Durata Therapeutic ... | BLAIR JAMES C | 10% Owner | Buy | C | 0.00 | 16,529 | 0 | 16,529 | 0 to 16.5 K |